Crown Point-based biotech firm developing diabetes drug former Merck exec describes as potential 'gamechanger'

The Munster Times

Dec 5, 2021

A Crown Point-based biotech firm is developing a new diabetes drug touted as a possible "gamechanger" for many with the chronic disease. |!| Munster Crown Point